We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.22%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$666B
AUM Growth
+$8.72B
Cap. Flow
+$1.57B
Cap. Flow %
0.24%
Top 10 Hldgs %
22.76%
Holding
14,701
New
2,078
Increased
5,000
Reduced
5,362
Closed
2,191

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$775M
2
ABBV icon
AbbVie
ABBV
+$540M
3
DAL icon
Delta Air Lines
DAL
+$434M
4
LLY icon
Eli Lilly
LLY
+$433M
5
DXCM icon
DexCom
DXCM
+$433M

Sector Composition

Rank Sector Weight
1 Technology 4.89%
2 Healthcare 2.92%
3 Financials 2.71%
4 Consumer Discretionary 2.52%
5 Industrials 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCSC icon
9226
PUT
Scansource
SCSC
$1.08B
$453K ﹤0.01%
+11,600
New +$479K
PLG
9227
Platinum Group Metals
PLG
$189M
$453K ﹤0.01%
191,969
+99,328
+107% +$240K
ONB icon
9228
CALL
Old National Bancorp
ONB
$10.4B
$453K ﹤0.01%
20,300
-2,000
-9% -$43.1K
CMPR icon
9229
CALL
Cimpress
CMPR
$2.3B
$453K ﹤0.01%
6,800
-9,600
-59% -$651K
VOXR
9230
Vox Royalty Corp
VOXR
$359M
$452K ﹤0.01%
95,446
-229,996
-71% -$1.04M
SPBC icon
9231
Simplify US Equity PLUS GBTC ETF
SPBC
$43.2M
$452K ﹤0.01%
+10,115
New +$453K
ANIK icon
9232
Anika Therapeutics
ANIK
$288M
$452K ﹤0.01%
47,066
+27,683
+143% +$265K
KALV
9233
CALL
DELISTED
KalVista Pharmaceuticals
KALV
$452K ﹤0.01%
+28,000
New +$371K
GFEB icon
9234
FT Vest US Equity Moderate Buffer ETF February
GFEB
$381M
$452K ﹤0.01%
+10,885
New +$446K
KROS icon
9235
CALL
Keros Therapeutics
KROS
$200M
$452K ﹤0.01%
22,200
+300
+1% +$5.26K
IRWD icon
9236
CALL
Ironwood Pharmaceuticals
IRWD
$712M
$452K ﹤0.01%
134,100
+107,400
+402% +$279K
ISMD icon
9237
Inspire Small/Mid Cap Impact ETF
ISMD
$347M
$452K ﹤0.01%
11,705
+5,961
+104% +$229K
TSLT icon
9238
PUT
T-REX 2X Long Tesla Daily Target ETF
TSLT
$152M
$451K ﹤0.01%
16,900
-24,600
-59% -$668K
CCS icon
9239
CALL
Century Communities
CCS
$2.01B
$451K ﹤0.01%
7,600
-11,200
-60% -$682K
TSHA icon
9240
PUT
Taysha Gene Therapies
TSHA
$1.94B
$451K ﹤0.01%
82,000
+56,300
+219% +$273K
BTCC
9241
Grayscale Bitcoin Covered Call ETF
BTCC
$14.3M
$451K ﹤0.01%
+20,960
New +$534K
KNTK icon
9242
PUT
Kinetik
KNTK
$4.3B
$451K ﹤0.01%
12,500
+7,700
+160% +$278K
NHI icon
9243
PUT
National Health Investors
NHI
$3.58B
$451K ﹤0.01%
5,900
+100
+2% +$7.67K
BSCX icon
9244
Invesco BulletShares 2033 Corporate Bond ETF
BSCX
$1.03B
$451K ﹤0.01%
20,994
-5,503
-21% -$118K
MCB icon
9245
CALL
Metropolitan Bank Holding Corp
MCB
$1.17B
$451K ﹤0.01%
5,900
-4,100
-41% -$304K
BBIN icon
9246
JPMorgan BetaBuilders International Equity ETF
BBIN
$6.58B
$450K ﹤0.01%
6,228
-25,312
-80% -$1.81M
MSFL icon
9247
GraniteShares 2x Long MSFT Daily ETF
MSFL
$85.1M
$450K ﹤0.01%
+16,562
New +$490K
AVMV icon
9248
Avantis US Mid Cap Value ETF
AVMV
$764M
$450K ﹤0.01%
+6,323
New +$439K
DXPE icon
9249
PUT
DXP Enterprises
DXPE
$3.12B
$450K ﹤0.01%
4,100
-2,400
-37% -$261K
FTBI
9250
First Trust Balanced Income ETF
FTBI
$23.1M
$450K ﹤0.01%
+21,150
New +$450K

Similar funds

Ken Griffin's Q4 2025 Portfolio in Review

As of Q4 2025, Ken Griffin held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
  • Ken Griffin added most to Amazon in Q4 2025, an estimated $2.49B increase.
  • Ken Griffin's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
  • Ken Griffin fully exited WEX in Q4 2025, selling an estimated $131M.
  • Ken Griffin's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
  • Ken Griffin opened 2,078 new positions and closed 2,191 in Q4 2025.
  • Ken Griffin's portfolio value rose 1.3% quarter-over-quarter to $666B.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.